Unknown

Dataset Information

0

High-efficiency enrichment enables identification of aptamers to circulating Plasmodium falciparum-infected erythrocytes.


ABSTRACT: Plasmodium falciparum is the causative agent of the deadliest human malaria. New molecules are needed that can specifically bind to erythrocytes that are infected with P. falciparum for diagnostic purposes, to disrupt host-parasite interactions, or to deliver chemotherapeutics. Aptamer technology has the potential to revolutionize biological diagnostics and therapeutics; however, broad adoption is hindered by the high failure rate of the systematic evolution of ligands by exponential enrichment (SELEX). Here we performed parallel SELEX experiments to compare the impact of two different methods for single-strand recovery on the efficiency of aptamer enrichment. Our experimental results and analysis of SELEX publications spanning 13 years implicate the alkaline denaturation step as a significant cause for inefficient aptamer selection. Thus, we applied an exonuclease single-strand recovery step in our SELEX to direct aptamers to the surface of erythrocytes infected with P. falciparum. The selected aptamers bind with high affinity (low nanomolar Kd values) and selectivity to exposed surface proteins of both laboratory parasite strains as well isolates from patients in Asia and Africa with clinical malaria. The results obtained in this study potentially open new approaches to malaria diagnosis and surveillance.

SUBMITTER: Oteng EK 

PROVIDER: S-EPMC7298056 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

High-efficiency enrichment enables identification of aptamers to circulating Plasmodium falciparum-infected erythrocytes.

Oteng Eugene K EK   Gu Wenjuan W   McKeague Maureen M  

Scientific reports 20200616 1


Plasmodium falciparum is the causative agent of the deadliest human malaria. New molecules are needed that can specifically bind to erythrocytes that are infected with P. falciparum for diagnostic purposes, to disrupt host-parasite interactions, or to deliver chemotherapeutics. Aptamer technology has the potential to revolutionize biological diagnostics and therapeutics; however, broad adoption is hindered by the high failure rate of the systematic evolution of ligands by exponential enrichment  ...[more]

Similar Datasets

| S-EPMC2696463 | biostudies-literature
| S-EPMC4114535 | biostudies-literature
| S-EPMC3621960 | biostudies-literature
| S-EPMC7449074 | biostudies-literature
| S-EPMC6496086 | biostudies-literature
| S-EPMC4797390 | biostudies-literature
| S-EPMC3428085 | biostudies-literature
| S-EPMC4032238 | biostudies-literature
| S-EPMC3615419 | biostudies-literature
| S-EPMC1173160 | biostudies-literature